BiotechTube
Home/NovelMed Therapeutics/Rekha Bansal, PhD
RB

Rekha Bansal, PhD

Chief Executive Officer

NovelMed Therapeutics

Therapeutic Areas

HematologyNephrologyOphthalmologyRheumatologyNeurologyRare Diseases

NovelMed Therapeutics Pipeline

DrugIndicationPhase
Ruxoprubart (NM8074)Paroxysmal Nocturnal Hemoglobinuria (PNH)Phase 2
NM5072Geographic Atrophy (GA) / Wet Age-Related Macular DegenerationPhase 1/2 (not specified)